Occurrence of Potential Adverse Drug Events from Prescribing Errors in a Pediatric Intensive and High Dependency Unit in Hong Kong: An Observational Study
Chad A. Knoderer
Part of the Medical Sciences Commons
Works by Chad A. Knoderer in Medical Sciences
2017
Student Pharmacists' Comfort and Ability Assessing and Recommending Doses in Pediatric Patients
Chad A. Knoderer
2016
Characterization of Clinical Outcomes with Cefepime in a Neonatal Intensive Care Unit: A Retrospective Cohort Study
Chad A. Knoderer
Organization and Programming of Pediatric Pharmacy Advocacy Group-Affiliated Student Chapters
Chad A. Knoderer
Population Pharmacokinetics (PK) of Vancomycin (VAN) in Neonates on Extra-Corporeal Life Support (ECLS)
Chad A. Knoderer
Comparison of Antibiotic Dosing Before and After Implementation of an Electronic Order Set
Chad A. Knoderer
2015
Population Pharmacokinetics (PK) of Vanomycin (VAN) in Neonates on Extra-Corporeal Life Support
Chad A. Knoderer
Population Pharmacokinetics (PK) of Vancomycin in Children on Extra-Corporeal Life Support (ECLS)
Chad A. Knoderer
Adherence to Anti-Infective Prescribing Recommendations in Institutional Febrile Neutropenia Guidelines
Chad A. Knoderer
Design and Evaluation of a Student Created Oral Exam Format in a Pediatric Elective
Chad A. Knoderer
A Retrospective Analysis of Clinical Outcomes with Continuous Versus Intermittent Nafcillin Infusions in Children
Chad A. Knoderer
2014
Comparing Clinical Outcomes in Sepsis: Aminoglycoside vs. Non-Aminoglycoside Containing Empiric Regimens
Chad A. Knoderer
Late Occurring Vancomycin-associated Acute Kidney Injury in Children Receiving Prolonged Therapy
Chad A. Knoderer
Population Pharmacokinetics (PK) and Pharmacodynamics (PD) of Extended-Infusion Piperacillin (PIP), Administered with Tazobactam (TAZ), in Critically Ill Children
Chad A. Knoderer
2013
Acid Suppressing Agents and Risk for Clostridium Difficile Infection in Pediatric Patients
Chad A. Knoderer